Adam Townsend

Adam Townsend joined as our chief commercial officer in November 2018. Prior to joining Apellis, Adam worked at Biogen in Cambridge, Massachusetts, from 2010 until October 2018, with progressive leadership roles in commercial and corporate development. Most recently, Adam served as senior vice president of corporate development. Prior to this, Adam was senior vice president of global marketing and commercial strategy, with global responsibility for the commercial teams involved with all late stage and commercial products. While at Biogen, Adam lead the successful launch of multiple blockbuster products in the neurology and rare disease space. Prior to working at Biogen, Adam held numerous leadership positions with increasing levels of responsibility in Europe: at EUSA Pharma as general manager of the UK, Ireland, and Nordic region and as the head of commercial, driving significant and consistent growth across multiple geographies. Prior to that, Adam worked for Amgen in Zug, Switzerland, as part of Amgen’s European marketing team, and in the UK, where he progressed to be Amgen’s head of marketing. Adam began his career in sales at Novartis UK. Adam received a BSc (Hons) degree in medical biochemistry from the University of London, UK.